Back

Potential role of Interleukin-18 in Pulmonary Arterial Hypertension in Systemic Sclerosis Patients

27 May 2018 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 2 - Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure – Clinical Pulmonary Hypertension HFA Premium Access Heart Failure 2018

About the speaker

Photo
Assistant Professor Yoshiyuki Orihara

Hyogo Medical University, Nishinomiya (Japan)

5 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Ms K. Cerlinskaite-Bajore (Vilnius, LT)
Abstract
Presentation thumbnail
Doctor E. Karelkina (Saint Petersburg, RU)
Abstract
Presentation thumbnail
Doctor M. Coronel (Corrientes, AR)
Abstract
Presentation thumbnail
Doctor V. Gregorietti (Buenos Aires, AR)
Abstract

Access the full session

Session thumbnail
Poster Session 2 - Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure – Clinical

The Event

Event poster

Heart Failure 2018

27 May 2018 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Right ventricular arterial coupling in PAH: idiopatic versus systemic sclerosis-associated pulmonary arterial hypertension
30 August 2025
thumbnail
Congress Presentation
Elevated interleukin-6 and interleukin-18 concentrations predict residual inflammatory risk both before and after interleukin-1beta inhibition with canakinumab
1 September 2019
thumbnail
Congress Presentation
Inhibin Beta-A is a novel gene involved in the development of pulmonary arterial hypertension through inhibiting BMPRII-signaling in endothelial cells
3 September 2019
thumbnail
Congress Presentation
Interleukin-22 inhibits right ventricular remodelling by a unique mechanism in a pulmonary artery constriction model.
30 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources